4.5 Article

Joint assessment of white matter integrity, cortical and subcortical atrophy to distinguish AD from behavioral variant FTD: A two-center study

Journal

NEUROIMAGE-CLINICAL
Volume 9, Issue -, Pages 418-429

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.nicl.2015.08.022

Keywords

Alzheimer's disease; Frontotemporal dementia; Gray matter atrophy; White matter integrity; Discriminant analyses; Diagnosis

Categories

Funding

  1. Alzheimer Nederland and Stichting VUMC Fonds
  2. Netherlands Initiative Brain and Cognition (NIHC)
  3. Netherlands Organization for Scientific Research (NWO) [056-13-014, 056-13-010]
  4. national project 'Brain and Cognition' Functionele Markers voor Cognitieve Stoornissen [056-13-014, 056-13-010]
  5. Merck Serono, Novartis
  6. Pfizer
  7. Alzheimer Nederland grant [2010-002]
  8. Dutch MS Society
  9. Netherlands Organisation for Scientific Research (NWO) [016.130.677]
  10. Alzheimer Nederland

Ask authors/readers for more resources

Weinvestigated the ability of cortical and subcortical gray matter (GM) atrophy in combinationwith whitematter (WM) integrity to distinguish behavioral variant frontotemporal dementia (bvFTD) fromAlzheimer3s disease (AD) and from controls using voxel-based morphometry, subcortical structure segmentation, and tract-based spatial statistics. To determine which combination of MR markers differentiated the three groups with the highest accuracy, we conducted discriminant function analyses. Adjusted for age, sex and center, both types of dementia had more GM atrophy, lower fractional anisotropy (FA) and higher mean (MD), axial (L1) and radial diffusivity (L23) values than controls. BvFTD patients had more GM atrophy in orbitofrontal and inferior frontal areas than AD patients. In addition, caudate nucleus and nucleus accumbenswere smaller in bvFTD than in AD. FA values were lower; MD, L1 and L23 values were higher, especially in frontal areas of the brain for bvFTD compared to AD patients. The combination of cortical GM, hippocampal volume and WM integrity measurements, classified 97-100% of controls, 81-100% of AD and 67-75% of bvFTD patients correctly. Our results suggest that WM integrity measures add complementary information to measures of GM atrophy, thereby improving the classification between AD and bvFTD. (C) 2015 The Authors. Published by Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available